Visioneering Technologies, Inc Names Kuang-Mon Tuan as Chief Medical Officer
November 04, 2021 at 06:16 pm EDT
Share
Visioneering Technologies, Inc. named Kuang-mon (Ashley) Tuan, OD, PhD, FAAO as Chief Medical Officer. In her new position, Dr. Tuan will be responsible for managing clinical research studies, such as the NaturalVue? (etafilcon A) Multifocal randomized clinical trial for myopia progression control in children, helping identify and develop new products, and leading efforts to communicate findings in key journals and scientific meetings. Dr. Taun will also lead VTI's Professional Services team as it communicates technical information on products and initiatives to eye care professionals. Mojo Vision, a smart contact lens company, Dr. Tuan focused on medical use cases and contact lens platform product strategy, contact lens system Research & Development with oversight of Clinical, Regulatory, Medical and Professional Affairs.
Visioneering Technologies, Inc. is a medical device company. The Company is primarily engaged in the design, manufacture, sale and distribution of a contact lens, the NaturalVue Multifocal 1 Day (NaturalVue MF) contact lens. The Company operates through two segments: North America and Europe / Asia-Pacific. The North America segment includes its operations in the United States and Canada. The Europe/Asia-Pacific segment includes its operations outside of North America. Its flagship product is the NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens for adults with Presbyopia and children with Myopia. The Company sells its contact lenses in the United States, Europe, Australia, New Zealand, Hong Kong, Singapore, Canada and Malaysia. The Company manages the warehousing and distribution of its products through a contract with a third-party logistics provider (the 3PL).
VISIONEERING TECHNOLOGIES, INC. 
